Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis

Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis

Program Overview

This CME/CE program will highlight novel BTK (Bruton’s tyrosine kinase) inhibitors and their effects on adaptive and innate immunity in multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will review BTK inhibitor science as a therapeutic target to reduce neuroinflammation and damage to the CNS in patients with MS. The faculty will analyze the ...
View Course
Advanced Therapeutic Strategies and Family Planning for Women with Multiple Sclerosis

Advanced Therapeutic Strategies and Family Planning for Women with Multiple Sclerosis

Program Overview

This program is derived from content presented at the Consortium of Multiple Sclerosis Centers (CMSC) 34th Annual Meeting. This CME/CE activity will highlight advanced therapeutic strategies and family planning best practices for women with multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will analyze the immunopathology, epidemiology, and immune therapeutic targets for MS. Recent ...
View Course
Novel Treatment Strategies to Improve Outcomes in Patients with Relapsing Remitting Multiple Sclerosis

Novel Treatment Strategies to Improve Outcomes in Patients with Relapsing Remitting Multiple Sclerosis

Program Overview

This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel treatment strategies to improve outcomes in patients with relapsing remitting multiple sclerosis (RRMS). The expert faculty will review the science of relapsing remitting multiple sclerosis, including risk mitigation and the pharmacokinetics of current therapeutic ...
View Course

Novel S1P-Based Therapeutics to Improve Outcomes and Reduce Disability in Patients with Relapsing Multiple Sclerosis

Novel S1P-Based Therapeutics to Improve Outcomes and Reduce Disability in Patients with Relapsing Multiple Sclerosis

Program Overview

This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel S1P-based therapeutics to improve outcomes and reduce disability in patients with relapsing multiple sclerosis. The expert faculty will review the recent science of newer S1P-based therapeutics for the treatment of patients with relapsing multiple ...
View Course

A Scientific Overview of the Pharmacological and Non-Pharmacological Treatment Strategies for Parkinson’s Disease

A Scientific Overview of the Pharmacological and Non-Pharmacological Treatment Strategies for Parkinson’s Disease

Program Overview

This continuing medical education program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), including data presented at the International Congress of Parkinson’s Disease and Movement Disorders (MDS) 2019 in Nice, France.  The three expert faculty will review the pathophysiology of Parkinson’s disease, as well as best practices for early detection and ...
View Course
An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes

An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes

Program Overview

This CME activity will review recent advances in the improvement CGRP Inhibitors & Therapeutic Implementation as presented at the American Headache Society (AHS) 2019 Philadelphia, PA. The expert faculty will discuss the immunologic and pathogenic mechanisms of CGRP as well as strategies for implementation of novel CGRP inhibitors into patient-specific treatments. The faculty will also analyze safety, efficacy, ...
View Course
Reducing the Risk of Relapse in Patients with Relapsing Forms of Multiple Sclerosis

Reducing the Risk of Relapse in Patients with Relapsing Forms of Multiple Sclerosis

Program Overview

This CME program will highlight recent advances in the treatment and management of multiple sclerosis (MS), with a focus on best practices for reducing risk in patients with relapsing forms of MS. The expert faculty will analyze current guidelines and recommendations, highlighting the definitions of MS activity, progression, and worsening. Various emerged and emerging agents for the treatment ...
View Course
Advances in the Diagnosis and Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults

Advances in the Diagnosis and Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults

Program Overview

This CME program is derived from content presented at the Florida Society of Neurology 2019 held in Orlando, Florida on September 13, 2019. The expert faculty will discuss the importance of patient screening, accurate diagnosing, and cross-disciplinary approaches for the management of Hereditary Transthyretin-Mediated Amyloidosis (hATTR). This includes a review the most recent clinical trial data for the ...
View Course
Clinical Update of Disease Modifying Therapies for the Management of Parkinson’s Disease

Clinical Update of Disease Modifying Therapies for the Management of Parkinson’s Disease

Program Overview

This CME program is derived from content presented at the Florida Society of Neurology 2019 held in Orlando, Florida on September 13, 2019. The expert faculty will provide an overview of current and emerging therapies for the treatment of Parkinson’s disease. This includes an a review of proper patient screenings and novel therapeutic approaches. The faculty will also ...
View Course
Integration of Personalized Medicine into the Management of Patients with Multiple Sclerosis

Integration of Personalized Medicine into the Management of Patients with Multiple Sclerosis

Program Overview

This CME program is derived from content presented at the Florida Society of Neurology 2019 Annual Meeting held in Orlando, Florida. The expert faculty will discuss the importance of personalized treatment strategies to more effectively care for patients with multiple sclerosis. This includes a review of current and emerging therapeutics for the treatment of highly active RRMS. The ...
View Course
Loading...